Cookie Policy         The Babraham Research Campus is also home to The Babraham Institute

  Babraham Bioscience Technologies
        Babraham Research Campus - Cambridge - UK


Video Library


Press Releases and Media Reports 2017



PhoreMost and Sixth Element Capital Announce Creation and Investment in NeoPhore, an Immuno-Oncology Company. More...

15th November 2017


Bicycle Therapeutics

MRC spin out Bicycle Therapeutics announces partnership with AstraZeneca in £1bn deal. More...

9th November 2017


Crescendo Biologics

Crescendo Biologics Shortlisted for ‘Licensing Deal of the Year’ at the Scrip Awards 2017. More...

1st November 2017


Sphere Fluidics

Sphere Fluidics' Cyto-Mine wins major European Product Innovation award. More...

1st November 2017


Babraham Research Campus

Babraham Research Campus announces new life science development. More...

26th October 2017


Babraham Bioscience Technologies Limited

The only meeting checklist you’ll ever need. More...

19th October 2017


Mission Therapeutics

Mission Therapeutics’ Scientists Highlight Significance Of Deubiquitylating Enzymes (Dubs) As Key Drug Targets. More...

2nd October 2017


Babraham Bioscience Technologies Limited

How to use social media to make your next event memorable. More...

26th September 2017


Bicycle Therapeutics

Bicycle Therapeutics Strengthens Senior Management Team With Appointment of Maria Koehler, M.D., Ph.D., as Chief Medical Officer. More...

26th September 2017


Babraham Bioscience Technologies Limited

A Peek Inside Europe’s Best Incubator: A Conversation with Babraham’s Chief Executive. More...

20th September 2017


Bicycle Therapeutics

Tiny Bicycle Therapeutics Wrangles a $424 Million R&D Pact With Biogen (BIIB) Spinoff Bioverativ (BIVV). More...

6th September 2017


Babraham Bioscience Technologies Limited

How to find the perfect venue for your next meeting. More...

5th September 2017


Babraham Bioscience Technologies Limited

Support for - The UK Life Science Strategy – ‘Making the UK the best place for life sciences businesses to grow'. More...

30th August 2017


Storm Therapeutics

STORM Therapeutics and Evotec AG in oncology drug push. More...

17th August 2017


Cambridge Epigenetix

Cambridge Epigenetix and NuGEN Technologies Sign Partnership Agreement to Combine Leading Technologies in Epigenetics Research. More...

15th August 2017



DefiniGEN announces collaboration with Kishida Chemical to develop their iPSC-derived disease model business in the Japanese pharmaceutical market. More...

3rd August 2017


Bicycle Therapeutics

Bicycle Therapeutics Expands Leadership Team with Appointment of Lee Kalowski as Chief Financial Officer. More...

1st August 2017



Kymab Announces Clinical Update On Its Promising New Antibody KY1005 For Treatment Of Autoimmune Diseases. More...

31st July 2017



Kymab antibody could counter side effects of bone marrow transplants. More...

31st July 2017


Cancer Research Technology

Cancer Research UK brings commercialisation arm in-house. More...

27th July 2017


Storm Therapeutics

Evotec AG (EVTG.F) Expands Collaboration With Storm Therapeutics On Its RNA Epigenetics Platform. More...

27th July 2017


Sphere Fluidics

Sphere Fluidics Limited and Partners Win Major Innovate UK Grant to Develop the World's First Desktop Genome Editing System. More...

17th July 2017



Abzena : OBI Pharma signs agreement with Abzena for ADC linker technology. More...

15th July 2017


Cambridge Science and Tech cluster

More ‘Killers’ on the loose in Cambridge Science and Tech cluster. More...

26th June 2017


Touchstone Innovations

Touchstone Invests GBP3.0 Million In Concirrus For 67% Stake. More...

19th June 2017



Anbtibodies powerhouse Kymab has appointed immunologist Dr Sonia Quaratino as its first chief medical officer. Dr Quaratino (pictured) will manage the clinical development of the group’s expanding therapeutic antibody portfolio. More...

15th June 2017


Artios Pharma

Arix Bioscience plc (LSE: ARIX) (“Arix Bioscience” or the “Company”), a global healthcare and life science company supporting medical innovation, is pleased to note the announcement by Artios Pharma Ltd, an Arix Bioscience Group Business, that it has signed a research collaboration and option agreement with Masaryk University (“MU”) in the Czech Republic for the development of novel cancer treatments targeting DNA nucleases involved in the DNA damage response (DDR). More...

12th June 2017


Cambridge Epigenetix

Epigenetics Experts Interview - Professor Wolf Reik. More...

6th June 2017



F-star tees up potential €1bn antibodies windfall from Merck. More...

4th June 2017



F-star Expands its Relationship with Merck through a new Strategic Collaboration to Develop Bispecific Antibodies in Immuno-Oncology. More...

4th June 2017


Bicycle Therapeutics

Bicycle Therapeutics Closes £40 Million ($52 Million) in Series B Financing to Advance Clinical Pipeline. More...

1st June 2017


Babraham Bioscience Technologies

Annual Babraham Investor Conference attracts over 120 investors focused on early-stage and scale-up life science and med-tech companies. More...

25th May 2017


Nemesis Bioscience

Nemesis Bioscience Closes Funding Round and Begins Preclinical Programmes. More...

8th May 2017


Bicycle Therapeutics

Bicycle Therapeutics Announces a Candidate Preclinical Milestone in Its Ophthalmology Alliance with ThromboGenics. More...

20th April 2017


Babraham Bioscience Technologies Limited

Biomed realty invests in the construction of labratory and office facilities at the Babraham Research Campus. More...

19th April 2017


Bicycle Therapeutics

Bicycle Therapeutics is Named Winner of Business Weekly’s Disruptive Technology Award 2017. More...

29th March 2017


Bicycle Therapeutics

Bicycle Therapeutics to Present at Cowen and Company 37th Annual Health Care Conference. More...

2nd March 2017


Storm Therapeutics

Storm Therapeutics announces appointment of CEO and Chairman. More...

24th February 2017


Rapid Biosensor Systems

SPIE Prism Award for Innovation in Biomedical Instrumentation and the winner is…The TB Breathalyser. More...

14th February 2017



SuperX completes $11m investment for anticoagulant antibodies. More...

9th February 2017



Kymab receives $9m grant from the Bill & Melinda Gates Foundation. More...

9th January 2017


Bicycle Therapeutics

Bicycle Therapeutics Appoints Nicholas Keen, Ph.D., as Chief Scientific Officer. More...

5th January 2017




Babraham Bioscience Technologies Ltd - Cambridge - United Kingdom